Published: 20 September 2017
Author(s): Luis Castilla-Guerra, María del Carmen Fernandez-Moreno, David Leon-Jimenez, Eduardo Carmona-Nimo
Section: Narrative Review

Cardiovascular disease (CVD) is the major cause of morbidity and mortality for individuals with type 2 diabetes (T2D). In particular, the risk for stroke is twice that of patients without diabetes, and diabetes may be responsible for >8% of first ischemic strokes. Therefore, the way to prevent stroke in these patients has become an important issue.Traditionally, glucose-lowering drugs had not been shown to protect against stroke. Moreover, several antidiabetic drugs (i.e., sulfonylureas, rosiglitazone) have been reported to be associated with increased risks of CVD and stroke.

Newsletters

Stay informed on our latest news!